EGFR-TKIs Induced DPP4 Drives Metabolic Reprogramming of Persister Cells in Lung Cancer

Two drug-tolerant persister lung cancer cells with different proliferative capacities were established and identified dipeptidyl peptidase 4 (DPP4) as a potential therapeutic target.